Dr. Hans Hammers M.D., PH.D.
Oncologist | Medical Oncology
1550 Orleans St Crb I - 1m42 Baltimore MD, 21231Rating
5/5
About
Dr. Hans Hammers is an oncologist practicing in Baltimore, MD. Dr. Hammers specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Hammers manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Differential expression of the B cell-restricted molecule CD22 on neonatal B lymphocytes depending upon antigen stimulation.
- Ultraviolet-induced detection of halogenated pyrimidines: simultaneous analysis of DNA replication and cellular markers.
- Improvement of the precision in CFU-GM and BFU-E counting by flow cytometry-based standardization of short-term culture assays.
- Introduction of a novel proliferation assay for pharmacological studies allowing the combination of BrdU detection and phenotyping.
- Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity.
- Withaferin A is a potent inhibitor of angiogenesis.
- Ultraviolet-induced detection of halogenated pyrimidines (UVID).
- Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study.
- Screening assay for blood vessel maturation inhibitors.
- Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial.
- Safety and clinical activity of vascular endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors after programmed cell death 1 inhibitor treatment in patients with metastatic clear cell renal cell carcinoma.
- Evaluation of a novel mononuclear cell isolation procedure for serological HLA typing.
- Evaluation of a flow cytometric method for simultaneous leukocyte phenotyping and quantification by fluorescent microspheres.
Clinical Trials
Dr. Hans Hammers M.D., PH.D.'s Practice location
Dr. Hans Hammers M.D., PH.D.'s reviews
Write ReviewPatient Experience with Dr. Hammers
Recommended Articles
![]()
Can Liver Diseases Lead to Liver Cancer?What is a liver disease?Liver disease refers to medical complications that cause the liver to be damaged, making it unable to perform its functions properly. The liver is among the most valuable and life-sustaining organs in the body. The reason is that it carries out many important functions that...
![]()
Study Reveals Why Triple Negative Breast Cancer Is Resistant to ImmunotherapyMost breast cancer patients end up going through a lot of different treatments during their attempted recovery. Chemotherapy, surgery, immunotherapy, and more are often performed on just one patient. One particular problem that doctors have noticed is that one particular subtype of breast cancer,...
![]()
The Different Stages of Liver CancerStaging liver cancer is a procedure which aims to describe where your cancer is located, where it has spread to, and if it has affected other body parts or organs. Staging liver cancer is very important since it helps in determining the prognosis of your cancer and the most suitable treatment option...
![]()
Comparative Value of PARP Inhibitors is Lacking, According to ICER ReportThe Institute for Clinical and Economic Review, also known as ICER, is a non-profit organization that analyzes the value of new medical tests, treatments, and drugs approved by the U.S. Food and Drug Administration (FDA). The goal of ICER is to use the value of these innovations and develop reports...
![]()
Ovarian Cancer Survivor Dedicates Herself to Helping OthersJuly 11th, 2014 is a day LeToy Hannah will never forget. She had gone into surgery to remove a non-cancerous cyst on her ovary and came out with a stage 3C ovarian cancer diagnosis. Hannah was shocked; her mother had to make the call to do a complete hysterectomy to remove all visible cancer while...
![]()
Breast Cancer: New Research Confirms Deodorant Use Is Okay During RadiotherapyAntiperspirant is okay to wear while undergoing radiation treatment. That’s the finding from a recent study by the Perelman School of Medicine at the University of Pennsylvania.The study also concluded many doctors continue to advise patients against use of antiperspirants during radiotherapy, to...
Nearby Providers
![]()
Dr. Johann Brandes MD, PHD1650 Orleans Street Baltimore MD 21231![]()
Dr. Kit Lu M.D.4940 Eastern Ave Baltimore MD 21224![]()
Dr. Julie Brahmer M.D.401 North Broadway Baltimore Maryland 21231![]()
Dr. Ashraf Zarif Badros M.D.22 S. Greene St Baltimore MD 21263![]()
Dr. Ivan Marques Borrello M.D.1650 ORLEANS ST BALTIMORE MD 21263![]()
Dr. Douglas Gladstone M.D.1650 Orleans St Baltimore MD 21287
Nearest Hospitals
JOHNS HOPKINS HOSPITAL, THEl
600 NORTH WOLFE STREET BALTIMORE MD 21287KENNEDY KREIGER INSTITUTEl
707 NORTH BROADWAY BALTIMORE MD 21205PARKLAND HEALTH AND HOSPITAL SYSTEMl
5200 HARRY HINES BLVD DALLAS TX 75235UT SOUTHWESTERN UNIVERSITY HOSPITAL-ZALE LIPSHYl
5151 HARRY HINES BLVD DALLAS TX 75390